| 2.36 0.22 (10.28%) | 04-17 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
Xylo Technologies Ltd. operates as a technology-focused enterprise, providing a comprehensive range of medical devices and related products to international markets, encompassing the United States, Europe, Asia, and Israel. The company's diverse operations are organized into several distinct segments, including Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and other divisions. Among its medical innovations is the Medigus Ultrasonic Surgical Endostapler, an advanced endoscopy system specifically utilized for treating gastroesophageal reflux disease. Xylo Technologies also develops specialized biological gels, engineered to safeguard patients against biological threats and to minimize the intrusion of allergens and viruses through the upper respiratory passages and ocular areas. Beyond its healthcare offerings, the company maintains a significant presence in the digital sector. This includes furnishing a digital advertising platform, managing various online retail outlets for consumer products on the Amazon marketplace, and operating an online platform for event management and ticketing services. Furthermore, Xylo Technologies is actively engaged in pioneering wireless battery charging technologies for vehicles and developing modular electronic vehicles. The organization, which was previously known as Medigus Ltd., officially adopted its current name, Xylo Technologies Ltd., in April 2024. Established in 1999, the company maintains its corporate headquarters in Tel Aviv-Yafo, Israel.
Fri, 22 Aug 2025
L.I.A. Pure Capital Ltd. completed the acquisition of remaining 91.13% stake in Xylo Technologies Ltd. - marketscreener.com
Tue, 09 Apr 2024
Medigus Announces Corporate Rebranding Changes Name to Xylo Technologies Ltd. to Reflect Core Values of its Business - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |
|
|
|
|
|
|
|
|
|